Cancer Treatment and End-of-Life Care

J Palliat Med. 2018 Aug;21(8):1100-1106. doi: 10.1089/jpm.2017.0695. Epub 2018 May 16.

Abstract

Aim: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.

Patients and methods: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.

Results: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.

Conclusions: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).

Keywords: cancer; end-of-life; low/middle-income countries; specialized palliative care; tumor-specific treatment.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Decision Making
  • Female
  • Humans
  • India
  • Infant
  • Male
  • Middle Aged
  • Neoplasms / therapy*
  • Palliative Care / psychology*
  • Palliative Care / standards*
  • Practice Guidelines as Topic*
  • Referral and Consultation / statistics & numerical data*
  • Retrospective Studies
  • Terminal Care / psychology*
  • Terminal Care / standards*
  • Young Adult